PT-141 (10mg)

Description

What is PT-141 Peptide?

PT-141, also known as Bremelanotide, is a research peptide used in laboratory studies exploring libido, sexual function, and arousal pathways. It is a synthetic analog of alpha-MSH and functions as a melanocortin receptor agonist, primarily engaging MC3R and MC4R receptors in the central nervous system (CNS).

Unlike other compounds that act on vascular systems, PT-141 has been studied in preclinical settings for its central mechanisms of action. Research has investigated its influence on dopaminergic signaling, neuroendocrine pathways, and sexual motivation in both male and female models.

---

PT-141 Peptide Specifications

---

Why Choose BioEdge Research Labs PT-141?

• Research-Only Purity: Over 99% purity confirmed via independent HPLC testing.

• Secure, Sterile Packaging: Designed to protect structural integrity during shipment.

• Fast Shipping: Most orders ship within 24 hours after payment confirmation from our U.S.-based facility.

• Researcher-Focused Support: Dedicated customer support for licensed researchers.

---

Summary of Preclinical Research Findings

Studied for Libido and Arousal

Preclinical studies have explored PT-141′s role in sexual arousal, libido stimulation, and behavioral response in animal models. It is distinguished by its central action on melanocortin receptors, making it a focus of research in both male erectile response and female sexual motivation studies.

Sexual Function & Behavioral Research

Animal trials have assessed PT-141’s effects on dopamine-driven signaling, hypothalamic engagement, and exploratory behavior in controlled settings. Research suggests its influence on motivation circuits, particularly through modulation of the HPA axis and central arousal pathways.

Neurovascular & CNS Modulation

PT-141 has been studied for its ability to affect central vasodilation, neurovascular tone, and brain blood flow regulation. These studies aim to better understand CNS-based vascular responses associated with arousal and behavior.

---

Suggested Laboratory Research Applications

• Libido and arousal-related behavioral models

• Melanocortin receptor activation studies

• Female sexual motivation and HSDD research

• Central nervous system signaling exploration

• Neurovascular modulation studies

• Dopaminergic response and neuropeptide assays

These research applications are suggested for informational use only. BioEdge Research Labs makes no claims of therapeutic or diagnostic use.

---

Handling & Storage Guidelines

• Store lyophilized PT-141 peptide at room temperature upon delivery.

• Once reconstituted, refrigerate immediately and use within an appropriate time frame.

• Use sterile laboratory-grade solvents during preparation.

• Protect from direct light, excessive moisture, and heat to maintain stability.

---

For Research Use Only

BioEdge Research Labs’ PT-141 is provided strictly for scientific laboratory research.

• Not for human or animal consumption.

• Not for therapeutic, diagnostic, or clinical use.

• Not for resale or use outside of licensed laboratory protocols.

Purchase of this compound confirms that the buyer is a qualified researcher and agrees to adhere to all applicable safety, regulatory, and legal guidelines. You must be 18 years or older to purchase. BioEdge disclaims all liability for misuse.

---

Summary of References

PT-141 and Melanocortin Receptor Activation

• Shadiack, A. M., Carlson, K., Brioni, J. D., & Nelson, D. L. (2003). Melanocortins in the CNS activate pathways involved in male sexual arousal. Hormones and Behavior, 44(5), 419–426. https://www.ncbi.nlm.nih.gov/pubmed/12710982

• Navarro, C. M., Harper, A., & Rame, J. (2017). Melanocortin peptides: Biology, pharmacology, and therapeutic potential. NeuroMolecular Medicine, 19(1), 1–14. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384512/

PT-141 in Sexual Behavior and Desire Models

• Wessells, H., Gralnek, D., Dorr, R., Padma-Nathan, H., & Giuliano, F. (2008). Effect of an intranasal melanocortin receptor agonist in men with erectile dysfunction: A randomized double-blind placebo-controlled study. Journal of Sexual Medicine, 5(1), 6–17. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667525/

• Diamond, L. E., Earle, D. C., Rosen, R. C., Willett, M. S., & Molinoff, P. B. (2004). Double-blind, placebo-controlled evaluation of the safety and efficacy of PT-141, a melanocortin receptor agonist, in the treatment of hypoactive sexual desire disorder in premenopausal women. Journal of Sexual Medicine, 1(3), 363–373. https://www.ncbi.nlm.nih.gov/pubmed/17113634

• Kingsberg, S. A., Clayton, A. H., Portman, D., Simon, J. A., & DeRogatis, L. (2016). Bremelanotide for female sexual dysfunction: A randomized placebo-controlled dose-finding trial. Menopause, 23(10), 1052–1060. https://www.ncbi.nlm.nih.gov/pubmed/27181790

---

BioEdge Research Labs

Precision. Purity. Performance.

At BioEdge, we are committed to providing research professionals with the highest quality peptides on the market. Every compound we supply is manufactured in a cGMP-certified facility, undergoes rigorous third-party testing, and is intended strictly for in vitro or laboratory research use only.